GlassScriptPhysician profile
Clark Gerhart
NPI 1265400204
$317,274.63
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $92K · 2021: $77K · 2022: $114K · 2023: $15K · 2024: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $1,172 · Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $1,171.65 |
| Food and Beverage | $679.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $316,022.91 | 2019-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Janssen Pharmaceuticals, INC | $240.93 | 2019-2022 | |
| Ethicon US, LLC | $236.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $125.00 | 2020 | |
| Shire North American Group INC | $110.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.36 | 2020-2022 | |
| Medtronic, INC. | $86.63 | 2023 | Plasmablade(Tm) |
| Conmed Corporation | $84.51 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $40.55 | 2019 | |
| Baxter Healthcare | $39.32 | 2019-2021 | |
| Teleflex LLC | $33.97 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $31.88 | 2022 | |
| Tactile Systems Technology INC | $28.50 | 2020 | |
| Axonics, INC. | $20.08 | 2022 | |
| Acell, INC. | $17.89 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $17.01 | 2021 | |
| Organogenesis INC. | $15.41 | 2019 | |
| Smith+Nephew, INC. | $15.00 | 2021 | |
| Covidien LP | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Gerhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.